Oncocyte Announces Distribution Agreement with CORE Diagnostics, Expanding Commercial Availability of DetermaRx(TM) to India, the Middle East and Africa

Stock Information for OncoCyte Corporation

Loading

Please wait while we load your information from QuoteMedia.